Functional assaY Integrated for Hereditary Breast and Ovary Cancer genes - FYI-HBOC - BRCA1, CHEK2 and PALB2

Zhihua Chen; Thales Nepomuceno; Paulo C. M. Lyra, Jr.; Alvaro N.A. Monteiro

100%
STATUS: Deployed - http://iscva.moffitt.org/fyi-hboc/build/

Identification of Two Genetic Loci Associated with Leukopenia after Chemotherapy in Breast Cancer Patients

Peter Fasching, Duan Liu, Steve Scully, James Ingle, Paulo Lyra, Brigitte Rack, Alexander Hein, Arif Ekici, André Reis, Andreas Schneeweiss, Hans Tesch, Tanja Fehm, Georg Heinrich, Matthias Beckmann, Matthias Rübner, Hanna Hübner, Diether Lambrechts, Ebony Madden, Jess Shen, Jane Romm, Kimberly Doheny, Gregory Jenkins, Erin Carlson, Liang Li, Brooke Fridley, Julie Cunningham, Wolfgang Janni, Alvaro Monteiro, Daniel Schaid, Lothar Häberle, Richard Weinshilboum, and Liewei Wang

100%
STATUS: Submitting for publication

Two distinct mechanims underlie strogen receptor negative breast cancer susceptibility at the 2p23.2 locus

Gustavo Mendoza-Fandino; Carly M. Harro; Nicholas T. Woods, Paulo C. M. Lyra, Jr; Thales C. Nepomuceno; Xueli Li; Fergus J. Couch; Alvaro N.A Monteiro

95%
STATUS: Finalizing last version for first submission

Integration of functional assay data results to find evidences for classification of BRCA2 variants of uncertain significance

Paulo C. M. Lyra, Jr; Thales C. Nepomuceno; Marcelo A. Carvalho; Alvaro N.A Monteiro

10%
STATUS: Gathering initial data
Home